Chiropractors in Andrews, NC Accepting Medicare

5 Chiropractors found. Showing 1 - 5

Dr. Sierra Cutshaw, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 13882 Us 19, Andrews, NC 28901 Phone: 828-321-2225

Cutshaw Chiropractic Center, Inc Chiropractor Medicare: Medicare Enrolled Practice Location: 13882 Us Hwy 19, Whites Plaza, Andrews, NC 28901 Phone: 828-321-2225    Fax: 828-321-2225

Dr. Kevin M O'brien, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 18 Town Branch Rd, Andrews, NC 28901 Phone: 828-321-2173    Fax: 828-321-2173

Dr Kevin O Brien Dc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 18 Town Branch Road, Andrews, NC 28901 Phone: 828-321-2173    Fax: 828-321-2173

Dr. Shane Mcneil Cutshaw, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 13882 Us 19, Andrews, NC 28901 Phone: 828-321-2225    Fax: 828-321-2225

News Archive

Gay men who are HIV-positive rarely regret revealing their health status to others

The study, the first of its kind, could be important for clinicians who work with HIV-positive men who are often uncertain whether to tell friends, family, co-workers or others about being diagnosed with the virus that causes AIDS.

Behavioural therapy may benefit children with Tourette syndrome

Children with Tourette syndrome could benefit from behavioural therapy to reduce their symptoms, according to a new brain imaging study.

APS honors MCW professor with Henry Pickering Bowditch Lecture Award

High blood pressure, or hypertension, is a major problem worldwide, with the latest estimates suggesting that a billion people across the globe may have this condition. Hypertension not only takes an enormous cost on health and wellbeing, but it also exacts an expensive financial toll. Complications from this condition including kidney disease, and its resulting treatments, such as long-term dialysis and kidney transplant, are some of the costliest conditions the American health care system must contend with.

Positive results from Alkermes' ALKS 5461 phase 1/2 study on MDD

Alkermes plc today presented positive results from the phase 1/2 study of ALKS 5461, a novel drug compound for major depressive disorder (MDD) in patients who have an inadequate response to standard therapies for clinical depression, in an oral session at the 52nd Annual New Clinical Drug Evaluation Unit (NCDEU) Meeting in Phoenix.

StemCells seeks Swiss authorization to conduct human neural stem cells clinical trial in chronic spinal cord injury

StemCells, Inc. announced today that is has filed an application with Swissmedic, the Swiss regulatory agency for therapeutic products, to conduct a clinical trial in Switzerland of the Company's HuCNS-SC® purified human neural stem cells in chronic spinal cord injury patients. If authorized, the study would enroll patients who are three to 12 months post-injury.

Read more Medical News

› Verified 2 days ago